Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
April 17 2019 - 5:45AM
InvestorsHub NewsWire
501-3292
Production Way, Burnaby, B.C., V5A 4R4
Phone:
(604) 551-7831 Fax: 604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com
Cannabix
Technologies Provides
Update on
Marijuana Breathalyzer Development
The Cannabix Marijuana Breathalyzer
system
is being developed to give law enforcement and employers a tool to
enforce public safety.
Vancouver, British Columbia -- April 17, 2019 --
InvestorsHub NewsWire -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or
Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law
enforcement and the workplace, is pleased to report that recent
characterization work with Cannabix’s FAIMS (field asymmetric
waveform ion mobility spectrometry) THC detection device with human
subjects has shown the ability to consistently discriminate
unwanted ions from complex human breath background matrices
allowing for THC (9-tetrahydrocannabinol) detection. In
particular, recent testing with updated FAIMS cell geometries has
shown the ability to consistently supress several compounds that
are commonly found in breath like nicotine, garlic, onion, meats,
ethanol, and volatile flavorants such as methyl salicylate and
menthol (commonly found in gum) allowing for discrimination and
mobility of THC in exhaled breath.
The Company is also pleased to report
that engineers have developed a new atmospheric pressure
chemical ionization source that provides significantly improved ion
control in terms of intensity, stability, and focusing.
Early testing with high concentrations of
a range of interferents
collected from the breath of human
subjects did not affect
the sensitivity of the
FAIMS device. These
include complex matrices such as tomato juice and mouthwash.
Testing with various common high
salt and high
sugar content electrolyte drinks was
also conducted to
determine if adduct ions would form that could interfere with the device, thus
far none of these have done
so.
Cannabix scientists have been focusing their
efforts to complete characterization of FAIMS with various possible
breath and environmental contaminants and are nearing completion of this
phase of development. The Company then plans to initiate
third-party testing and piloting of the device. The Company has received interest in piloting from
both U.S. and Canadian law enforcement groups as well as other
organizations that drug test their employees.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a leader in
marijuana breathalyzer development for law enforcement and the
workplace. Cannabix has established breath testing technologies in
the pursuit of bringing durable, portable hand-held tools to market
to enhance detection of marijuana impaired driving offences on
roads at a time when marijuana is becoming legal in many global
jurisdictions. Cannabix is working to develop drug-testing devices
that will detect THC- the psychoactive component of marijuana that
causes intoxication- using breath samples. In particular, Cannabix
is focused on developing breath testing devices for detection of
recent use of THC, in contrast to urine testing for THC metabolite
that requires an invasive collection and reflects
previous usage
from days or even weeks earlier. The devices will also
be useful for other practical applications such as testing
employees in the workplace where impairment by THC can be
hazardous.
We seek Safe Harbor.
On
behalf of the Board of Directors
"Rav Mlait"
CEO
Cannabix Technologies Inc.
For further information,
contact the Company at
info@cannabixtechnologies.com
The
CSE has not reviewed and does not accept responsibility for the
adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking
information that involves various risks and uncertainties regarding
future events. Such forward-looking information can include without
limitation statements based on current expectations involving a
number of risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company's plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing "patent pending" technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cannabix Technologies (CSE:BLO)
Historical Stock Chart
From Oct 2023 to Oct 2024